PSPaula L. Díaz Sylvester

Paula L. Díaz Sylvester

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paula L. Díaz Sylvester has a total of 123 co-authors. Here are the top co-authors by number of shared publications:

  • Julio A. Copello

    Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL

    11 shared publications
  • Kathleen Groesch

    Department of Obstetrics and Gynecology at Southern Illinois University School of Medicine, Springfield, Illinois, USA; The Center for Clinical Research at Southern Illinois University School of Medicine Springfield, Illinois, USA

    8 shared publications
  • Laurent Brard

    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Southern Illinois University School of Medicine, Springfield, Illinois, United States of America

    6 shared publications
  • Maura Porta

    Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (P.L.D.-S., V.V.J., Y.L., J.A.C.); Department of Physiology, Midwestern University, Chicago School of Osteopathic Medicine, Downers Grove, Illinois (M.P.); and Departments of Biological Sciences and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee (S.F.)

    6 shared publications
  • Teresa Wilson

    Department of Obstetrics and Gynecology at Southern Illinois University School of Medicine, Springfield, Illinois, USA; The Center for Clinical Research at Southern Illinois University School of Medicine Springfield, Illinois, USA

    6 shared publications
  • Andrea Braundmeier-Fleming

    Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, 825 N Rutledge St, Springfield, IL 62702, USA; Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, Springfield, IL 62702, USA; Simmons Cancer Institute at Southern Illinois University (SIU) School of Medicine, 315 W. Carpenter St, Springfield, IL 62702, USA

    3 shared publications

Latest Publications

  • Open Access

    Epidural Anesthesia, Intrapartum Use of Synthetic Oxytocin and the Odds of Autistic Disorder

    by Stephen M. Soltys, Teresa Wilson, Albert Botchway, Kathleen Groesch, Paula Diaz-Sylvester, Pamela Campbell, Julio Ricardo Loret de Mola

  • Open Access

    Bioinformatics Analysis Identifies Lipid Droplet‐Associated Gene Signatures as Promising Prognostic and Diagnostic Models for Endometrial Cancer

    by Vijayalakshmi N. Ayyagari, Miao Li, Paula Diaz‐Sylvester, Kathleen Groesch, Teresa Wilson, Ejaz M. Shah, Laurent Brard

    Background: Effective diagnostic and prognostic tools are critical for early detection and improved outcomes in endometrial cancer (EC). Although metabolic dysregulation plays a key role in EC pathogenesis, the clinical relevance of lipid droplet–associated genes (LDAGs) remains largely unexplored. This study aims to establish LDAG‐based gene signatures with strong diagnostic and prognostic potential in EC.Aims: To identify LDAG signatures with prognostic and diagnostic utility in EC.Methods and Results: A curated set of LDAGs was systematically analyzed across publicly available EC datasets to identify differentially expressed LDAGs (DE‐LDAGs). Survival‐associated DE‐LDAGs were then identified using univariate Cox regression. A four‐gene prognostic model was developed through LASSO‐based feature selection followed by multivariate Cox regression and validated using Kaplan–Meier survival and time‐dependent receiver operating characteristic (ROC) analyses. From the same pool of survival‐associated DE‐LDAGs, a six‐gene diagnostic model was constructed using LASSO, ROC analysis, and logistic regression. Model performance was evaluated using ROC curves and support vector machine (SVM) classification. Functional enrichment and protein–protein interaction (PPI) network analyses were conducted to assess the biological relevance of the identified genes.Our results demonstrate that the four‐gene prognostic model (LMLN, LMO3, PRKAA2, and RAB10) stratified EC patients into high‐ and low‐risk groups with significantly different survival outcomes (p < 0.05; time‐dependent AUC > 0.70). The six‐gene diagnostic model (AIFM2, ABCG1, LIPG, DGAT2, LPCAT1, and VCP) demonstrated near‐perfect classification of tumor versus normal tissues (AUC ≈0.99 in ROC analysis; 99.8% accuracy in SVM analysis). Functional enrichment linked DE‐LDAGs to lipid metabolism, ER stress response, cholesterol homeostasis, and autophagy, underscoring their biological relevance in EC pathobiology.Conclusion: This study provides the first comprehensive analysis of LDAGs in EC, establishing robust prognostic and diagnostic gene signatures with strong biological relevance. These signatures support a metabolism‐driven framework for EC classification and may offer potential clinical utility in early detection, risk stratification, and personalized treatment.


  • Open Access

    Comprehensive Analysis of DGATs and PLINs in Ovarian Cancer: Implications for Diagnosis and Prognosis

    by Vijayalakshmi N. Ayyagari, Miao Li, Paula Diaz-Sylvester, Kathleen Groesch, Teresa Wilson, Zvi Pasman, Laurent Brard

    Background: Lipid droplet (LD) dynamics drive cancer cell proliferation, resistance, and aggressiveness. Diacylglycerol O‐acyltransferases (DGATs) and perilipins (PLINs) are key LD‐associated genes implicated in cancer pathophysiology. Objective: This study aimed to comprehensively analyze the expression and clinical significance of DGATs and PLINs in ovarian cancer (OC), focusing on their correlation with LDs and triglyceride (TG) levels, and to explore their diagnostic and prognostic implications. Methods: LD and TG levels in ovarian cell lines and clinical samples were assessed using BODIPY staining, fluorometric, colorimetric assays, and thin‐layer chromatography (TLC). Gene expression profiling of DGATs and PLINs in cell lines and tissue was conducted via RT‐qPCR, ELISA, and bioinformatics analysis. Correlation analyses between gene expression, Ki67, and survival data were performed. ROC curve analysis evaluated diagnostic potential. Results: LD accumulation was significantly higher in OC cell lines and tissues compared with normal controls. Diacylglycerol O‐acyltransferase 1 (DGAT1) and diacylglycerol O‐acyltransferase 2 (DGAT2) were overexpressed in OC cell lines and tissues, particularly in advanced stages (III and IV). Elevated TG levels were observed in OC cell lines and clinical samples, correlating with LD abundance and the expression of DGAT1 and DGAT2. PLIN2 and PLIN3 were significantly upregulated in OC tissues. Bioinformatics analysis identified dysregulation of DGATs and PLINs in OC. Survival analysis indicated DGAT2 is a predictor of poor prognosis. Diagnostic assessments revealed DGAT2 as a potential biomarker for OC detection. Conclusion: DGATs and PLINs are pivotal in LD metabolism and tumor progression in OC, with DGAT2 being a good candidate as prognostic and diagnostic marker. They present promising avenues for therapeutic targeting and diagnostic biomarkers, holding the potential to improve patient outcomes. Further exploration of their mechanistic roles and clinical implications is essential for advancing personalized cancer care.


  • Mapping of the Deep Epigastric Vessels Stratified by Body Mass Index (BMI)

    by Arturo Garza-Cavazos, Christopher-Armand Mabini, Maria Teresa Tam, Paula Diaz-Sylvester, Kathleen Groesch, Randall Robbs, Sara Lay, Teresa Wilson, J. Ricardo Loret de Mola, Sohail Siddique

  • Developmental Outcomes of Very Preterm Infants Conceived Through In Vitro Fertilization

    by Taylor Badger, Emma Johns, Teresa Wilson, Kathleen Groesch, Paula Diaz-Sylvester, Erin Bauer, Albert Botchway, Melanie Nielsen, Julio Ricardo Loret de Mola, Beau Batton

  • Open Access

    Influence of Hormonal Factors, Number of Sexual Partners, Surgical Intervention on Gastrointestinal and Urogenital Microbiota of Patients Endometriosis

    by Han Do, Paula Diaz-Sylvester, Kathleen Groesch, Teresa Wilson, Kristen Delfino, J.RIcardo Loret de Mola, Andrea Braundmeier-Fleming


  • Open Access

    Association of microbial dynamics with urinary estrogens and estrogen metabolites in patients with endometriosis

    by Nhung Le, Melissa Cregger, Veronica Brown, Julio Loret de Mola, Pamela Bremer, Lyn Nguyen, Kathleen Groesch, Teresa Wilson, Paula Diaz-Sylvester, Andrea Braundmeier-Fleming

    Endometriosis is an estrogen dependent gynecological disease associated with altered microbial phenotypes. The association among endogenous estrogen, estrogen metabolites, and microbial dynamics on disease pathogenesis has not been fully investigated. Here, we identified estrogen metabolites as well as microbial phenotypes in non-diseased patients (n = 9) and those with pathologically confirmed endometriosis (P-EOSIS, n = 20), on day of surgery (DOS) and ~1–3 weeks post-surgical intervention (PSI). Then, we examined the effects of surgical intervention with or without hormonal therapy (OCPs) on estrogen and microbial profiles of both study groups. For estrogen metabolism analysis, liquid chromatography/tandem mass spectrometry was used to quantify urinary estrogens. The microbiome data assessment was performed with Next generation sequencing to V4 region of 16S rRNA. Surgical intervention and hormonal therapy altered gastrointestinal (GI), urogenital (UG) microbiomes, urinary estrogen and estrogen metabolite levels in P-EOSIS. At DOS, 17β-estradiol was enhanced in P-EOSIS treated with OCPs. At PSI, 16-keto-17β-estradiol was increased in P-EOSIS not receiving OCPs while 2-hydroxyestradiol and 2-hydroxyestrone were decreased in P-EOSIS receiving OCPs. GI bacterial α-diversity was greater for controls and P-EOSIS that did not receive OCPs. P-EOSIS not utilizing OCPs exhibited a decrease in UG bacterial α-diversity and differences in dominant taxa, while P-EOSIS utilizing OCPs had an increase in UG bacterial α-diversity. P-EOSIS had a strong positive correlation between the GI/UG bacteria species and the concentrations of urinary estrogen and its metabolites. These results indicate an association between microbial dysbiosis and altered urinary estrogens in P-EOSIS, which may impact disease progression.


  • Open Access

    Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression—An in vitro study

    by Vijayalakshmi N. Ayyagari, Xinjia Wang, Paula L. Diaz-Sylvester, Kathleen Groesch, Laurent Brard

    Abnormal accumulation of acyl-CoA cholesterol acyltransferase-1 (ACAT-1) mediated cholesterol ester has been shown to contribute to cancer progression in various cancers including leukemia, glioma, breast, pancreatic and prostate cancers. However, the significance of ACAT-1 and cholesterol esters (CE) is relatively understudied in ovarian cancer. In this in vitro study, we assessed the expression and contribution of ACAT-1 in ovarian cancer progression. We observed a significant increase in the expression of ACAT-1 and CE levels in a panel of ovarian cancer cell lines (OC-314, SKOV-3 and IGROV-1) compared to primary ovarian epithelial cells (normal controls). To confirm the tumor promoting capacity of ACAT-1, we inhibited ACAT-1 expression and activity by treating our cell lines with an ACAT inhibitor, avasimibe, or by stable transfection with ACAT-1 specific short hairpin RNA (shRNA). We observed significant suppression of cell proliferation, migration and invasion in ACAT-1 knockdown ovarian cancer cell lines compared to their respective controls (cell lines transfected with scrambled shRNA). ACAT-1 inhibition enhanced apoptosis with a concurrent increase in caspases 3/7 activity and decreased mitochondrial membrane potential. Increased generation of reactive oxygen species (ROS) coupled with increased expression of p53 may be the mechanism(s) underlying pro-apoptotic action of ACAT-1 inhibition. Additionally, ACAT-1 inhibited ovarian cancer cell lines displayed enhanced chemosensitivity to cisplatin treatment. These results suggest ACAT-1 may be a potential new target for the treatment of ovarian cancer.


  • Open Access

    Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer

    by Ruizhong Miao, Taylor C. Badger, Kathleen Groesch, Paula L. Diaz-Sylvester, Teresa Wilson, Allen Ghareeb, Jongjin Anne Martin, Melissa Cregger, Michael Welge, Colleen Bushell, et al.

    Epithelial ovarian cancer (OC) is the most deadly cancer of the female reproductive system. To date, there is no effective screening method for early detection of OC and current diagnostic armamentarium may include sonographic grading of the tumor and analyzing serum levels of tumor markers, Cancer Antigen 125 (CA-125) and Human epididymis protein 4 (HE4). Microorganisms (bacterial, archaeal, and fungal cells) residing in mucosal tissues including the gastrointestinal and urogenital tracts can be altered by different disease states, and these shifts in microbial dynamics may help to diagnose disease states. We hypothesized that the peritoneal microbial environment was altered in patients with OC and that inclusion of selected peritoneal microbial features with current clinical features into prediction analyses will improve detection accuracy of patients with OC. Blood and peritoneal fluid were collected from consented patients that had sonography confirmed adnexal masses and were being seen at SIU School of Medicine Simmons Cancer Institute. Blood was processed and serum HE4 and CA-125 were measured. Peritoneal fluid was collected at the time of surgery and processed for Next Generation Sequencing (NGS) using 16S V4 exon bacterial primers and bioinformatics analyses. We found that patients with OC had a unique peritoneal microbial profile compared to patients with a benign mass. Using ensemble modeling and machine learning pathways, we identified 18 microbial features that were highly specific to OC pathology. Prediction analyses confirmed that inclusion of microbial features with serum tumor marker levels and control features (patient age and BMI) improved diagnostic accuracy compared to currently used models. We conclude that OC pathogenesis alters the peritoneal microbial environment and that these unique microbial features are important for accurate diagnosis of OC. Our study warrants further analyses of the importance of microbial features in regards to oncological diagnostics and possible prognostic and interventional medicine.


  • Rural–urban differences in surgical treatment, regional lymph node examination, and survival in endometrial cancer patients

    by Whitney E. Zahnd, Katherine S. Hyon, Paula Diaz-Sylvester, Sonya R. Izadi, Graham A. Colditz, Laurent Brard

    Endometrial cancer (EC) is the most common gynecological malignancy and one of few cancers with an increasing US mortality rate. Rural patients may have less access to specialty care affecting their receipt of surgery and adequate lymphadenectomy (AL). We sought to assess rural–urban differences in EC surgery, lymphadenectomy, and survival.